"The landmark results of the IMPACT trial suggest a window of opportunity in early childhood to induce remission of peanut allergy through oral immunotherapy."
"Barriers to implementation are important to address since pediatricians, beginning with the 4-6 month well-child visits, can have a vital role in the reduction of peanut allergy.”
5 year multi-site study shows egg OIT was significantly more likely to achieve sustained unresponsiveness compared to children opting for baked egg therapy.